Essa Pharma Is A Clinical Stage Pharmaceutical Company Based In Vancouverbritish Columbiadedicated To Developing Innovative Therapies For Prostate Cancerthe Company Operates In The Biotechnology Sector And Is Listed On The Nasdaq Under The Ticker Symbol Epix Essa Pharma Focuses On Creating Small Molecule Drugs That Disrupt The Androgen Receptor Signaling Pathwaya Critical Factor In Prostate Cancer Growththeir Lead Candidatemasofanitenformerly Epi 7386 Offers A New Method Of Targeting This Pathway By Selectively Binding To The N Terminal Domain Of The Androgen Receptorthis Approach Aims To Enhance Androgen Suppression And Delay Resistance To Existing Therapiesparticularly For Patients With Castration Resistant Prostate Cancer Who Have Not Responded To Second Generation Anti Androgen Treatmentswith A Small Team Of 11 50 Employeesessa Pharma Emphasizes A Specialized Approach To Its Research And Development Efforts
